US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0212-1 D-0676-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0211-1 D-0675-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0210-1 D-0674-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0209-1 D-0673-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0206-1 D-0672-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0205-1 D-0671-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0204-1 D-0670-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0203-1 D-0669-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0202-1 D-0668-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0112-1 D-0667-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0111-1 D-0666-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0107-1 D-0665-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0106-1 D-0664-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0105-1 D-0663-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0104-1 D-0662-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0103-1 D-0661-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0102-1 D-0660-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0101-1 D-0659-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0100-1 D-0658-2023
Class II · Moderate risk Terminated

Transplant Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0014-2 D-0657-2023
Class II · Moderate risk Terminated

Microplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0012-2 D-0656-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0011-1 D-0655-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0009-1 D-0654-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0008-1 D-0653-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0007-1 D-0652-2023